Literature DB >> 2684645

Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor.

D Becker1, C B Meier, M Herlyn.   

Abstract

Human malignant melanomas, unlike normal melanocytes, can proliferate in the absence of exogenous basic fibroblast growth factor (bFGF). Exposure of primary melanomas in the vertical growth phase and metastatic melanomas to antisense oligodeoxynucleotides targeted against three different sites of human bFGF mRNA inhibited cell proliferation and colony formation in soft-agar. In contrast, exposure of human bFGF sense or antisense oligonucleotides complementary to human beta-nerve growth factor or insulin-like growth factor I mRNA had no such effects. These experiments indicate that activation of the bFGF gene may play an important role in the progression from melanocytic precursor lesions to malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684645      PMCID: PMC402051          DOI: 10.1002/j.1460-2075.1989.tb08543.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

1.  The biologic forms of malignant melanoma.

Authors:  W H Clark; D E Elder; M Van Horn
Journal:  Hum Pathol       Date:  1986-05       Impact factor: 3.466

2.  Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome.

Authors:  M H Greene; W H Clark; M A Tucker; D E Elder; K H Kraemer; D Guerry; W K Witmer; J Thompson; I Matozzo; M C Fraser
Journal:  N Engl J Med       Date:  1985-01-10       Impact factor: 91.245

3.  An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.

Authors:  G Anfossi; A M Gewirtz; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Effect of fibroblast growth factor on the division and fusion of bovine myoblasts.

Authors:  D Gospodarowicz; J Weseman; J S Moran; J Lindstrom
Journal:  J Cell Biol       Date:  1976-08       Impact factor: 10.539

5.  Characteristics of cultured human melanocytes isolated from different stages of tumor progression.

Authors:  M Herlyn; J Thurin; G Balaban; J L Bennicelli; D Herlyn; D E Elder; E Bondi; D Guerry; P Nowell; W H Clark
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

6.  Isolation of the human insulin-like growth factor genes: insulin-like growth factor II and insulin genes are contiguous.

Authors:  G I Bell; D S Gerhard; N M Fong; R Sanchez-Pescador; L B Rall
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

7.  Cytogenetics of human malignant melanoma and premalignant lesions.

Authors:  G Balaban; M Herlyn; D Guerry; R Bartolo; H Koprowski; W H Clark; P C Nowell
Journal:  Cancer Genet Cytogenet       Date:  1984-04

8.  Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.

Authors:  A H Ross; P Grob; M Bothwell; D E Elder; C S Ernst; N Marano; B F Ghrist; C C Slemp; M Herlyn; B Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Karyotypic evolution in human malignant melanoma.

Authors:  G B Balaban; M Herlyn; W H Clark; P C Nowell
Journal:  Cancer Genet Cytogenet       Date:  1986-01-01

10.  A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.

Authors:  W H Clark; D E Elder; D Guerry; M N Epstein; M H Greene; M Van Horn
Journal:  Hum Pathol       Date:  1984-12       Impact factor: 3.466

View more
  57 in total

1.  Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.

Authors:  T A Tetzke; M C Caton; P A Maher; Z Parandoosh
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

2.  The proliferative and morphologic responses of a colon carcinoma cell line (LIM 1215) require the production of two autocrine factors.

Authors:  A M Sizeland; A W Burgess
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

3.  Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition.

Authors:  Thomas Metzner; Alexandra Bedeir; Gerlinde Held; Barbara Peter-Vörösmarty; Sara Ghassemi; Christine Heinzle; Sabine Spiegl-Kreinecker; Brigitte Marian; Klaus Holzmann; Bettina Grasl-Kraupp; Christine Pirker; Michael Micksche; Walter Berger; Petra Heffeter; Michael Grusch
Journal:  J Invest Dermatol       Date:  2011-07-14       Impact factor: 8.551

4.  Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis.

Authors:  Dongfang Liu; Zachary Shriver; Ganesh Venkataraman; Yosuf El Shabrawi; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

5.  A vaccine targeting basic fibroblast growth factor elicits a protective immune response against murine melanoma.

Authors:  Xiaoping Zhang; Neng-Lian Li; Chao Guo; Ying-Dong Li; Lu-Lu Luo; Yong-Qi Liu; Yun-Yan Duan; Zhen-Dong Li; Xiao-Rong Xie; Hai-Xia Song; Li-Ping Yang; Fang-Yu An
Journal:  Cancer Biol Ther       Date:  2018-03-06       Impact factor: 4.742

Review 6.  Inhibition of fibroblast growth factors.

Authors:  A Wellstein; F Czubayko
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin.

Authors:  C Berking; R Takemoto; K Satyamoorthy; R Elenitsas; M Herlyn
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

8.  MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma.

Authors:  Simone Braig; Daniel W Mueller; Tanja Rothhammer; Anja-Katrin Bosserhoff
Journal:  Cell Mol Life Sci       Date:  2010-05-18       Impact factor: 9.261

9.  Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma.

Authors:  Michael G Gartside; Huaibin Chen; Omar A Ibrahimi; Sara A Byron; Amy V Curtis; Candice L Wellens; Ana Bengston; Laura M Yudt; Anna V Eliseenkova; Jinghong Ma; John A Curtin; Pilar Hyder; Ursula L Harper; Erica Riedesel; Graham J Mann; Jeffrey M Trent; Boris C Bastian; Paul S Meltzer; Moosa Mohammadi; Pamela M Pollock
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

10.  Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma.

Authors:  Suyun Huang; Lisa Mills; Badar Mian; Carmen Tellez; Marya McCarty; X-D Yang; Jean M Gudas; Menashe Bar-Eli
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.